Fred Aslan
Director, Chief Executive Officer · 1 filing · Latest: May 19, 2026
Artiva Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ARTV | Fred Aslan | Director, Chief Executive Officer | May 19, 2026 | Sale | $9.01 | 27,116 | $244.3K | 1,535,082 |